Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R T Davidson

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Journal of Traumatic Stress|November 1, 2006
Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorderBarbara O Rothbaum, Shawn P Cahill, Edna B Foa, et al.
The American Journal of Psychiatry|January 29, 2005
Neuroactive steroids and suicidality in posttraumatic stress disorderMarian I Butterfield, Karen M Stechuchak, Kathryn M Connor, et al.
Psychopharmacology|February 5, 2008
Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findingsNaomi M Simon, Kathryn M Connor, Richard T LeBeau, et al.
The Journal of Clinical Psychiatry|April 8, 2010
International consensus statement on major depressive disorderDavid J Nutt, Jonathan R T Davidson, Alan J Gelenberg, et al.
Journal of Clinical Psychopharmacology|May 7, 2005
Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression TrialBenedetto Vitiello, Richard I Shader, Corette B Parker, et al.
The American Journal of Psychiatry|August 3, 2004
Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorderJonathan D Huppert, Luke T Schultz, Edna B Foa, et al.
Assessment|March 4, 2014
Examining the factor structure of the Connor-Davidson Resilience Scale (CD-RISC) in a post-9/11 U.S. military veteran sampleKimberly T Green, Laura C Hayward, Ann M Williams, et al.
The Journal of Clinical Psychiatry|January 24, 2006
High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trialPhilip T Ninan, Lorrin M Koran, Ari Kiev, et al.
Archives of General Psychiatry|October 7, 2004
Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobiaJonathan R T Davidson, Edna B Foa, Jonathan D Huppert, et al.
Journal of Psychopharmacology (Oxford, England)|November 8, 2005
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for PsychopharmacologyDavid S Baldwin, Ian M Anderson, David J Nutt, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Journal of Traumatic Stress|November 1, 2006
Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorderBarbara O Rothbaum, Shawn P Cahill, Edna B Foa, et al.
The American Journal of Psychiatry|January 29, 2005
Neuroactive steroids and suicidality in posttraumatic stress disorderMarian I Butterfield, Karen M Stechuchak, Kathryn M Connor, et al.
Psychopharmacology|February 5, 2008
Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findingsNaomi M Simon, Kathryn M Connor, Richard T LeBeau, et al.
The Journal of Clinical Psychiatry|April 8, 2010
International consensus statement on major depressive disorderDavid J Nutt, Jonathan R T Davidson, Alan J Gelenberg, et al.
Journal of Clinical Psychopharmacology|May 7, 2005
Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression TrialBenedetto Vitiello, Richard I Shader, Corette B Parker, et al.
The American Journal of Psychiatry|August 3, 2004
Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorderJonathan D Huppert, Luke T Schultz, Edna B Foa, et al.
Assessment|March 4, 2014
Examining the factor structure of the Connor-Davidson Resilience Scale (CD-RISC) in a post-9/11 U.S. military veteran sampleKimberly T Green, Laura C Hayward, Ann M Williams, et al.
The Journal of Clinical Psychiatry|January 24, 2006
High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trialPhilip T Ninan, Lorrin M Koran, Ari Kiev, et al.
Archives of General Psychiatry|October 7, 2004
Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobiaJonathan R T Davidson, Edna B Foa, Jonathan D Huppert, et al.
Journal of Psychopharmacology (Oxford, England)|November 8, 2005
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for PsychopharmacologyDavid S Baldwin, Ian M Anderson, David J Nutt, et al.
Pageof 11